🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04105036
Active, not recruiting Observational

Social Deprivation Assessment in Older Adults

NCT04105036 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2020-04-01
Last updated
2024-09-19

Condition(s) studied

GeriatricsSocial Deprivation

Investigational drug(s) / intervention(s)

Data Collection

Data Collection: Telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site

Study summary

Social deprivation is a state to which older adults may be exposed, leading to adverse social, psychological, and health outcomes. Social deprivation may be more sensitive than socioeconomic status for predicting adversity while using only a few items for evaluation. However, there is no practical assessment for social deprivation in older Canadian adults. Two indices that capture a broad picture of social vulnerability have previously been developed for older Canadians. Using participants in the Canadian Longitudinal Study on Aging (CLSA), the overall objective is to examine and compare the associations of the COAD score and index, as well as the Keefe et al. and Andrew et al. indices with prevalent and incident adverse social, psychological, and health outcomes in participants at baseline assessment.

Eligibility

Sex
ALL
Min age
45 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants of the comprehensive CLSA assessment. Exclusion Criteria: * No information on social status * No information on social, psychological, and health outcomes

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jewish General Hospital Montreal Quebec

More Jewish General Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04105036 on ClinicalTrials.gov ↗ ← All trials in Canada